vs
Amphastar Pharmaceuticals, Inc.（AMPH）とnull（SWIM）の財務データ比較。上の社名をクリックして会社を切り替えられます
Amphastar Pharmaceuticals, Inc.の直近四半期売上が大きい（$183.1M vs $100.0M、nullの約1.8倍）。Amphastar Pharmaceuticals, Inc.の純利益率が高く（13.3% vs -7.0%、差は20.4%）。nullの前年同期比売上増加率が高い（14.5% vs -1.8%）。Amphastar Pharmaceuticals, Inc.の直近四半期フリーキャッシュフローが多い（$24.6M vs $14.1M）。過去8四半期でAmphastar Pharmaceuticals, Inc.の売上複合成長率が高い（3.2% vs -4.9%）
Amphastar Pharmaceuticalsは上場されている米国の特殊製薬企業です。2004年5月に設立され、主に吸入剤および鼻腔内投与製品の開発、生産、販売を行っており、特色ある医薬品分野で事業を展開しています。
米国発祥の多国籍法律事務所で、1934年にカリフォルニア州ロサンゼルスで設立されました。訴訟業務、企業法務、規制関連法務の分野で豊富な実績を持ち、世界的にも影响力のある総合法律事務所として知られています。
AMPH vs SWIM — 直接比較
売上が大きい
AMPH
1.8倍大きい
$100.0M
売上成長率が高い
SWIM
+16.4%の差
-1.8%
純利益率が高い
AMPH
純利益率が20.4%高い
-7.0%
フリーキャッシュフローが多い
AMPH
FCF $10.5M多い
$14.1M
2年売上CAGRが高い
AMPH
2年複合成長率
-4.9%
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $183.1M | $100.0M |
| 純利益 | $24.4M | $-7.0M |
| 粗利率 | 46.8% | 28.0% |
| 営業利益率 | 19.4% | -10.7% |
| 純利益率 | 13.3% | -7.0% |
| 売上前年比 | -1.8% | 14.5% |
| 純利益前年比 | -35.7% | 76.0% |
| EPS（希薄化後） | $0.51 | $-0.06 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上AMPHSWIM
| Q4 25 | $183.1M | $100.0M | ||
| Q3 25 | $191.8M | $161.9M | ||
| Q2 25 | $174.4M | $172.6M | ||
| Q1 25 | $170.5M | $111.4M | ||
| Q4 24 | $186.5M | $87.3M | ||
| Q3 24 | $191.2M | $150.5M | ||
| Q2 24 | $182.4M | $160.1M | ||
| Q1 24 | $171.8M | $110.6M |
純利益AMPHSWIM
| Q4 25 | $24.4M | $-7.0M | ||
| Q3 25 | $17.4M | $8.1M | ||
| Q2 25 | $31.0M | $16.0M | ||
| Q1 25 | $25.3M | $-6.0M | ||
| Q4 24 | $38.0M | $-29.2M | ||
| Q3 24 | $40.4M | $5.9M | ||
| Q2 24 | $37.9M | $13.3M | ||
| Q1 24 | $43.2M | $-7.9M |
粗利率AMPHSWIM
| Q4 25 | 46.8% | 28.0% | ||
| Q3 25 | 51.4% | 35.4% | ||
| Q2 25 | 49.6% | 37.1% | ||
| Q1 25 | 50.0% | 29.5% | ||
| Q4 24 | 46.5% | 24.6% | ||
| Q3 24 | 53.3% | 32.4% | ||
| Q2 24 | 52.2% | 33.1% | ||
| Q1 24 | 52.4% | 27.7% |
営業利益率AMPHSWIM
| Q4 25 | 19.4% | -10.7% | ||
| Q3 25 | 13.2% | 13.3% | ||
| Q2 25 | 24.2% | 14.3% | ||
| Q1 25 | 21.9% | -4.4% | ||
| Q4 24 | 24.2% | -14.9% | ||
| Q3 24 | 29.8% | 8.9% | ||
| Q2 24 | 30.3% | 12.5% | ||
| Q1 24 | 27.9% | -1.9% |
純利益率AMPHSWIM
| Q4 25 | 13.3% | -7.0% | ||
| Q3 25 | 9.0% | 5.0% | ||
| Q2 25 | 17.8% | 9.3% | ||
| Q1 25 | 14.8% | -5.4% | ||
| Q4 24 | 20.4% | -33.4% | ||
| Q3 24 | 21.1% | 3.9% | ||
| Q2 24 | 20.8% | 8.3% | ||
| Q1 24 | 25.1% | -7.1% |
EPS（希薄化後）AMPHSWIM
| Q4 25 | $0.51 | $-0.06 | ||
| Q3 25 | $0.37 | $0.07 | ||
| Q2 25 | $0.64 | $0.13 | ||
| Q1 25 | $0.51 | $-0.05 | ||
| Q4 24 | $0.74 | $-0.24 | ||
| Q3 24 | $0.78 | $0.05 | ||
| Q2 24 | $0.73 | $0.11 | ||
| Q1 24 | $0.81 | $-0.07 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $282.8M | — |
| 総負債低いほど良い | $608.7M | $279.8M |
| 株主資本純資産 | $788.8M | $405.9M |
| 総資産 | $1.6B | $823.2M |
| 負債/資本比率低いほどレバレッジが低い | 0.77× | 0.69× |
8四半期トレンド — 暦四半期で整列
現金・短期投資AMPHSWIM
| Q4 25 | $282.8M | — | ||
| Q3 25 | $276.2M | — | ||
| Q2 25 | $231.8M | — | ||
| Q1 25 | $236.9M | — | ||
| Q4 24 | $221.6M | — | ||
| Q3 24 | $250.5M | — | ||
| Q2 24 | $217.8M | — | ||
| Q1 24 | $289.6M | — |
総負債AMPHSWIM
| Q4 25 | $608.7M | $279.8M | ||
| Q3 25 | $608.6M | $281.1M | ||
| Q2 25 | $607.7M | $281.5M | ||
| Q1 25 | $603.9M | $306.9M | ||
| Q4 24 | $601.6M | $281.5M | ||
| Q3 24 | $596.4M | $282.8M | ||
| Q2 24 | $586.9M | $282.4M | ||
| Q1 24 | $594.0M | $282.8M |
株主資本AMPHSWIM
| Q4 25 | $788.8M | $405.9M | ||
| Q3 25 | $776.7M | $408.4M | ||
| Q2 25 | $757.5M | $398.4M | ||
| Q1 25 | $751.3M | $381.1M | ||
| Q4 24 | $732.3M | $387.2M | ||
| Q3 24 | $727.7M | $416.6M | ||
| Q2 24 | $713.3M | $408.1M | ||
| Q1 24 | $672.4M | $391.8M |
総資産AMPHSWIM
| Q4 25 | $1.6B | $823.2M | ||
| Q3 25 | $1.7B | $844.4M | ||
| Q2 25 | $1.6B | $822.1M | ||
| Q1 25 | $1.6B | $824.6M | ||
| Q4 24 | $1.6B | $794.2M | ||
| Q3 24 | $1.5B | $853.4M | ||
| Q2 24 | $1.5B | $830.0M | ||
| Q1 24 | $1.6B | $808.6M |
負債/資本比率AMPHSWIM
| Q4 25 | 0.77× | 0.69× | ||
| Q3 25 | 0.78× | 0.69× | ||
| Q2 25 | 0.80× | 0.71× | ||
| Q1 25 | 0.80× | 0.81× | ||
| Q4 24 | 0.82× | 0.73× | ||
| Q3 24 | 0.82× | 0.68× | ||
| Q2 24 | 0.82× | 0.69× | ||
| Q1 24 | 0.88× | 0.72× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $32.9M | $23.3M |
| フリーキャッシュフロー営業CF - 設備投資 | $24.6M | $14.1M |
| FCFマージンFCF / 売上 | 13.4% | 14.1% |
| 設備投資強度設備投資 / 売上 | 4.5% | 9.2% |
| キャッシュ転換率営業CF / 純利益 | 1.35× | — |
| 直近12ヶ月FCF直近4四半期 | $121.2M | $38.0M |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローAMPHSWIM
| Q4 25 | $32.9M | $23.3M | ||
| Q3 25 | $52.6M | $51.0M | ||
| Q2 25 | $35.6M | $36.0M | ||
| Q1 25 | $35.1M | $-46.9M | ||
| Q4 24 | $29.0M | $6.2M | ||
| Q3 24 | $60.0M | $37.2M | ||
| Q2 24 | $69.1M | $52.4M | ||
| Q1 24 | $55.3M | $-34.5M |
フリーキャッシュフローAMPHSWIM
| Q4 25 | $24.6M | $14.1M | ||
| Q3 25 | $47.2M | $45.2M | ||
| Q2 25 | $25.0M | $29.1M | ||
| Q1 25 | $24.4M | $-50.3M | ||
| Q4 24 | $16.6M | $-98.0K | ||
| Q3 24 | $46.2M | $33.2M | ||
| Q2 24 | $63.1M | $47.9M | ||
| Q1 24 | $46.5M | $-39.9M |
FCFマージンAMPHSWIM
| Q4 25 | 13.4% | 14.1% | ||
| Q3 25 | 24.6% | 27.9% | ||
| Q2 25 | 14.3% | 16.8% | ||
| Q1 25 | 14.3% | -45.2% | ||
| Q4 24 | 8.9% | -0.1% | ||
| Q3 24 | 24.1% | 22.1% | ||
| Q2 24 | 34.6% | 29.9% | ||
| Q1 24 | 27.1% | -36.0% |
設備投資強度AMPHSWIM
| Q4 25 | 4.5% | 9.2% | ||
| Q3 25 | 2.8% | 3.6% | ||
| Q2 25 | 6.1% | 4.0% | ||
| Q1 25 | 6.3% | 3.1% | ||
| Q4 24 | 6.7% | 7.2% | ||
| Q3 24 | 7.2% | 2.7% | ||
| Q2 24 | 3.3% | 2.8% | ||
| Q1 24 | 5.1% | 4.8% |
キャッシュ転換率AMPHSWIM
| Q4 25 | 1.35× | — | ||
| Q3 25 | 3.03× | 6.29× | ||
| Q2 25 | 1.15× | 2.25× | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 0.76× | — | ||
| Q3 24 | 1.48× | 6.32× | ||
| Q2 24 | 1.82× | 3.95× | ||
| Q1 24 | 1.28× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AMPH
| Other Products | $62.4M | 34% |
| Baqsimi | $46.7M | 26% |
| Primatenemist | $27.9M | 15% |
| Epinephrine | $17.1M | 9% |
| Lidocaine | $14.9M | 8% |
| Glucagon | $14.1M | 8% |
SWIM
| In Ground Swimming Pools | $50.2M | 50% |
| Covers | $37.0M | 37% |
| Liners | $12.7M | 13% |
